BAXTER HEALTHCARE - SINGAPORE
Manufacturer adverse-event records for BAXTER HEALTHCARE - SINGAPORE come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2008–2019 · heavy-book · typical Death-code · injury-light
Injury-mix signature
BAXTER HEALTHCARE - SINGAPORE is lighter on Injury codes
Injury-coded event_type share is 0.8% (injury-light tercile) beside 0.66% Death-coded (typical). Volume band: heavy.
What the Injury-mix reading shows for BAXTER HEALTHCARE - SINGAPORE
The standout signal for BAXTER HEALTHCARE - SINGAPORE is Injury-mix: 0.8% Injury-coded (injury-light) beside 0.66% Death-coded, on a heavy-book footprint.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BAXTER HEALTHCARE - SINGAPORE with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 12 device types, led in this extract by Malfunction at 72,135 (98.4% of event_type total). Peak single-year volume reaches 37,295 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (12)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.